Next Article in Journal
Molecular Neurobiology and Promising New Treatment in Depression
Next Article in Special Issue
Telomeres, NAFLD and Chronic Liver Disease
Previous Article in Journal
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
Previous Article in Special Issue
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(3), 281;

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach

Traslational Research Unit, Médica Sur Clinic & Foundation, Mexico City 14050, Mexico
Obesity and Digestive Diseases Unit, Médica Sur Clinic & Foundation, Mexico City 14050, Mexico
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Academic Editor: Amedeo Lonardo
Received: 23 December 2015 / Revised: 19 February 2016 / Accepted: 19 February 2016 / Published: 15 March 2016
(This article belongs to the Special Issue Non-Alcoholic Fatty Liver Disease Research 2016)
Full-Text   |   PDF [816 KB, uploaded 15 March 2016]   |  


Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition that can progress to nonalcoholic steatohepatitis, cirrhosis and cancer. It is considered an emerging health problem due to malnourishment or a high-fat diet (HFD) intake, which is observed worldwide. It is well known that the hepatocytes’ apoptosis phenomenon is one of the most important features of NAFLD. Thus, this review focuses on revealing, through a proteomics approach, the complex network of protein interactions that promote fibrosis, liver cell stress, and apoptosis. According to different types of in vitro and murine models, it has been found that oxidative/nitrative protein stress leads to mitochondrial dysfunction, which plays a major role in stimulating NAFLD damage. Human studies have revealed the importance of novel biomarkers, such as retinol-binding protein 4, lumican, transgelin 2 and hemoglobin, which have a significant role in the disease. The post-genome era has brought proteomics technology, which allows the determination of molecular pathogenesis in NAFLD. This has led to the search for biomarkers which improve early diagnosis and optimal treatment and which may effectively prevent fatal consequences such as cirrhosis or cancer. View Full-Text
Keywords: proteomics; NAFLD; mitochondrial dysfunction proteomics; NAFLD; mitochondrial dysfunction

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Nuño-Lámbarri, N.; Barbero-Becerra, V.J.; Uribe, M.; Chávez-Tapia, N.C. Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach. Int. J. Mol. Sci. 2016, 17, 281.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top